My Cart [ 0 ]
New Products
New Services
Promotions
News
Home > Research-Grade Biosimilars
Recombinant research-grade biosimilars (RUO) have the same protein sequences of therapeutic grade biologics (proteins and antibodies) with lower prices (starting from $30/mg for bulk order). For research use only.
    49 Research-Grade Biosimilars Products
  • C101P: Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody

    Recombinant Human IgG1 Kappa Monoclonal Antibody.
    Specificity/Sensitivity: The sotrovimab biosimilar specifically binds to the spike protein of SARS-CoV-2.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by sotrovimab.

  • C100P: Casirivimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody

    Recombinant Human IgG1 Kappa Monoclonal Antibody.
    Specificity/Sensitivity: The casirivimab biosimilar specifically binds to the spike protein of SARS-CoV-2.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by casirivimab.

  • C009P: Trastuzumab Biosimilar, HER2/ErbB-2/c-neu Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody trastuzumab biosimilar specifically binds to the human HER2 / ErbB-2 / c-neu.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by trastuzumab.

  • C001P: Bevacizumab Biosimilar, Human VEGF Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody generated from the same parent mouse antibody as ranibizumab.
    Specificity/Sensitivity: The monoclonal antibody bevacizumab biosimilar specifically binds to the human VEGF-A.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bevacizumab.

  • C024P: Atezolizumab Biosimilar, PD-L1 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade atezolizumab biosimilar specifically binds to the human PDL1 protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by atezolizumab.

  • C003P: Adalimumab Biosimilar, TNF alpha Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody adalimumab biosimilar specifically binds to the human TNF alpha.
    Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by adalimumab.

  • C022P: Eculizumab Biosimilar, Human C5 Monoclonal Antibody

    Recombinant Humanized IgG2/4 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody Eculizumab biosimilar specifically binds to the human C5, the terminal complement component 5.
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays.

  • C004P: Denosumab Biosimilar, Human RANKL Monoclonal Antibody

    Recombinant Humanized IgG2 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody denosumab biosimilar specifically binds to the human RANKL (RANK ligand) protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by denosumab.

  • C025P: Durvalumab Biosimilar, PD-L1 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade durvalumab biosimilar specifically binds to the human programmed cell death ligand 1 (PD-L1), blocking its interaction with PD-1 and B7-1.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by durvalumab.

  • C030P: Daratumumab Biosimilar, CD38 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade daratumumab biosimilar specifically binds to the human CD38 protein, causing cells to apoptose via antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, inhibition of mitochondrial transfer or antibody-dependent cellular phagocytosis.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by daratumumab.

See our Privacy Policy